Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31632742 | 1.00 | GAA (0.48) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL31632714 | 1.00 | GAA (0.48) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL31632755 | 1.00 | GAA (0.48) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL13622259 | 1.00 | GAA (0.48) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL13622262 | 1.00 | GAA (0.48) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL31632746 | 1.00 | GAA (0.48) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL31632732 | 0.96 | GAA (0.47) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL31632722 | 0.96 | GAA (0.47) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL31632724 | 0.96 | GAA (0.47) | GAATSHRNAAANPSR1MAPT | |
| SCHEMBL31632700 | 0.96 | GAA (0.47) | GAATSHRNAAANPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| US-20090285868-A1 | Photostable cosmetic compositions comprising dibenzoylmethane/pyrrolidinone compounds | L'OREAL (FR) | 2009-11-19 | — | — | US | disclosed |
| US-20090285868-A1 | Photostable cosmetic compositions comprising dibenzoylmethane/pyrrolidinone compounds | L'OREAL (FR) | 2009-11-19 | — | — | US | disclosed |
| EP-2119429-A1 | Cosmetic composition containing a dibenzoylmethane derivative and a pyrrolidinone derivative; method for photostabilising the dibenzoylmethane derivative | L'Oréal (FR) | 2009-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285868-A1 | Photostable cosmetic compositions comprising dibenzoylmethane/pyrrolidinone compounds | NOTUM, CYP51A1, DHPS | GAA 3156/4885TSHR 4230/4885NAAA 3665/4885 |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | GAA 2993/4885TSHR 3371/4885NAAA 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.